(Q33783243)

29 July 2017

Chest computed tomography predicts the frequency of pulmonary exacerbations in children with cystic fibrosis (English)

1 reference

29 July 2017

0 references

1 reference

Don B Sanders

1

1 reference

PubMed ID

25474182

29 July 2017

Zhanhai Li

series ordinal

2

1 reference

PubMed ID

25474182

29 July 2017

Alan S Brody

series ordinal

3

1 reference

29 July 2017

1 January 2015

1 reference

Proceedings of the American Thoracic Society

29 July 2017

1 reference

29 July 2017

12

1 reference

29 July 2017

1

1 reference

29 July 2017

64-69

1 reference

Scoring of chest CT in children with cystic fibrosis: state of the art.

29 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Cystic fibrosis pulmonary guidelines. Chronic medications for maintenance of lung health

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Chest computed tomography: a validated surrogate endpoint of cystic fibrosis lung disease?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Chest computed tomography scores of severity are associated with future lung disease progression in children with cystic fibrosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Bronchiectasis and pulmonary exacerbations in children and young adults with cystic fibrosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbation

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Association between mucoid Pseudomonas infection and bronchiectasis in children with cystic fibrosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Use of lung imaging studies as outcome measures for development of new therapies in cystic fibrosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

An overview of endpoints for cystic fibrosis clinical trials: one size does not fit all.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Classifying severity of cystic fibrosis lung disease using longitudinal pulmonary function data

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Predictive 5-year survivorship model of cystic fibrosis

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Surrogate end points in clinical trials: are we being misled?

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5466157

Progressive damage on high resolution computed tomography despite stable lung function in cystic fibrosis

4 July 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Impact of bronchiectasis and trapped air on quality of life and exacerbations in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Chest computed tomography scores are predictive of survival in patients with cystic fibrosis awaiting lung transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

High-resolution computed tomography in young patients with cystic fibrosis: distribution of abnormalities and correlation with pulmonary function tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Impact of recent pulmonary exacerbations on quality of life in patients with cystic fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Nationwide trends in the medical care costs of privately insured patients with cystic fibrosis (CF), 2001-2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Radiologic imaging in cystic fibrosis: cumulative effective dose and changing trends over 2 decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1513%2FANNALSATS.201407-338OC

Lung Clearance Index and HRCT are complementary markers of lung abnormalities in young children with CF

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Pulmonary exacerbations are associated with subsequent FEV1 decline in both adults and children with cystic fibrosis

1 reference

12 December 2020

Identifying the origins of cystic fibrosis lung disease

1 reference

12 December 2020

Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way?

1 reference

12 December 2020

10.1513/ANNALSATS.201407-338OC

Identifiers

DOI

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

PubMed ID

25474182